Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bayer Schering Pharma claims novel series of adenosine A1 agonists

Dec. 4, 2009

Roche reports encouraging results from phase III trials of taspoglutide in diabetes

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

EMEA accepts clinical development plan for DiaPep-277

Dec. 3, 2009

Biovitrum discovers novel GPR119 agonists for the treatment of obesity

Dec. 3, 2009

Ardea Biosciences reports results from combination trial of RDEA-594 and febuxostat

Dec. 3, 2009

Plethora Solutions and Columbia Laboratories execute marketing agreement for Striant SR

Dec. 3, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

Pfizer and Protalix to develop and commercialize taliglucerase alfa for Gaucher's disease

Dec. 2, 2009

CB1 receptor antagonists described by sanofi-aventis for the treatment of obesity

Dec. 1, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...